Does glibenclamide influence the clearance of insulin and glucose uptake in patients with type 2 diabetes mellitus?

References

• Beck-Nielsen H., Hother-Nielsen O., Pedersen O. Mechanism of action of sulphylureas with special reference to the extrapancreatic effect: an overview. Diabetic Medicine 1988; 5: 613–20
   PubMed Web of Science ®Google Scholar
• Ferrannini E., Wahren J., Faber O., Felig P., Binder C., DeFronzo R. A. Splachnic and renal metabolism of insulin in human subjects: a dose response study. Am J Physiol 1983; 244: E517–27
   Google Scholar
• Rubsenstein A. H., Pottenger L. A., Mako M., Getz G. S., Steiner D. F. The metabolism of proinsulin and insulin by the liver. J Clin Invest, 51: 912–21
   PubMed Web of Science ®Google Scholar
• Field J. B. Extraction of insulin by liver. Ann Rev Med 1974; 24: 309–14
   Web of Science ®Google Scholar
• Tillil H., Shapiro T., Rubsenstein A., Galloway J., Polonsky K. Reduction of insulin clearance during hyperglycemic clamp. Dose-response study in normal humans. Diabetes 1988; 37: 1351–7
   PubMed Web of Science ®Google Scholar
• Heidenreich K. A., Olefsky J. M. The metabolism of insulin receptors. Molecular basis of insulin action, M. P. Czeck. Plenum, New York 1985; 45–65
   Google Scholar
• Aimér L-O, Johansson E., Melander A., Wahlin-Boll E. Infleunce of sulphonylureas on the secretion, disposal and effect of insulin. Eur J Clin Pharmacol 1982; 22: 27–32
   PubMed Web of Science ®Google Scholar
• Scheen A. J., Lefebvre J. P., Luyckx A. S. Glipizide increases plasma insluin but not c-peptide level after a standardized breakfast in type 2 diabetic patients. Eur J Clin Pharmacol 1984; 26: 471–4
   PubMed Web of Science ®Google Scholar
• Lev J. D., Zeidler A., Kumar D. Glyburide and glipizide in treatment of diabetic patients with secondary failures to tolazamide or chlorpropamide. Diabetes Care 1987; 10: 679–82
   PubMed Web of Science ®Google Scholar
• Groop L., Groop P. H., Stenman S., Saloranta C., Tötterman K.-J, Fyhrqvist F., Melander A. Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment. Diabetes Care 1987; 10: 671–8
   PubMed Web of Science ®Google Scholar
• Hother-Nielsen O., Schmitz O., Andersen P. H., Beck-Nielsen H. In vivo action of glibenclamide in obese subjects with mild type 2 (non-insulin-dependent) diabetes. Diabetes Res 1988; 8: 63–70
   PubMedGoogle Scholar
• Polonsky K. S., Rubenstein A. H. C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations. Diabetes 1984; 33: 486–94
   PubMed Web of Science ®Google Scholar
• Nyomba B. L., Freymond D., Raz I., Stone K., Mott D. M., Bogardus C. Skeletal muscle glycogen synthase activity in subjects with non-insulin-dependent diabetes mellitus after glyburide therapy. Metabolism 1990; 39: 1204–10
   PubMed Web of Science ®Google Scholar
• Simonson D., Ferrannini E., Bevilacqua S., Smith D., Barrett E., Carlson R., DeFronzo R. A. Mechanism of improvement in glucose metabolism after chronic glyburide therapy. Diabetes 1984; 33: 838–45
   PubMed Web of Science ®Google Scholar
• Greenfield M. S., Dobeme L., Rosenthal M., Schulz B., Widstrom A., Reaven G. Effects of sulphonyl-urea treatment on in vivo insulin secretion and action in patients with non-insulin-dependent diabetes mellitus. Diabetes 1982; 31: 307–12
   PubMed Web of Science ®Google Scholar
• Kolterman O. G., Gray R. S., Shapiro G., Scarlett J A, Griffin J., Olefsky J. M. The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects. Diabetes 1984; 33: 838–45
   PubMed Web of Science ®Google Scholar
• Best J. D., Judzewitch R. G., Pfeifer M. A., Beard J. C., Halter J., Porte D. The effect of chronic sulfonylurea theapy on hepatic glucose production in non-insulin-dependent diabetes. Diabetes 1982; 31: 333–8
   PubMed Web of Science ®Google Scholar
• Grunberger G., Ryan J., Gorden P. Sulfonylureas do not affect insulin binding or glycemic control in insulin-dependent diabetics. Diabetes 1982; 31: 890–6
   PubMed Web of Science ®Google Scholar
• Ratzmann K. P., Schulz B., Heinke P., Besch W. Tolbutamide does not alter insulin requirement in type 1 (insulin-dependent) diabetes. Diabetologia 1984; 27: 8–12
   PubMed Web of Science ®Google Scholar
• Harano Y., Ohgaku S., Kosugi K., Yasuda H., Nakano T., Kobayashi M., Hidaka H., Izumi K., Kashiwagi A., Shigeta Y. Clinical significance of altered insulin sensitivity in diabetes mellitus assessed by glucose, insulin and somatostatin infusion. J Clin Endocrinol Metab 1981; 52: 982–7
   PubMed Web of Science ®Google Scholar
• Groop L. C., Ratheiser K., Luzi L., Melander A., Simonson D. C., Petrides A., Bonadonna R. C., Widén E., DeFronzo R. A. Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response study. Acta Diabetol 1991; 28: 162–8
   PubMed Web of Science ®Google Scholar
• Dixon W. J. BMDP statistical software manual. University of California Press, Berkeley 1988
   Google Scholar
• Holman R. R., Turner R. C. Basal normoglycemia attained with chlorpropamide in mild diabetes. Metabolism 1978; 27: 539–47
   PubMed Web of Science ®Google Scholar
• Sönksen P. H., Lowy C., Perkins J. R., West E. T. Hormonal and metabolic effects of chlorpropamide, glibenclamide and placebo in a crossover study in diabetics not controlled on diet alone. Diabetologia 1981; 20: 22–30
   PubMed Web of Science ®Google Scholar
• Elkeles R. S., Heding L. G., Paisey R. B. The long-term effects of chlorpropamide on insulin, C-peptide, and proinsulin secretion. Diabetes Care 1982; 4: 427–9
   Google Scholar
• Sartor G., Scherstén B., Melander A. Effects of glipizide and food intake on the blood levels of glucose and insulin in diabetic patients. Acta Med Scand 1978; 203: 211–4
   PubMedGoogle Scholar
• Duckworth W. C., Solomon S. S., Kitabchi A. E. Effect of chronic sulphonylurea therapy on plasma insulin and porinsulin levels. J Clin Endocrinol Metab 1972; 35: 585–91
   PubMed Web of Science ®Google Scholar
• Barnes A. J., Crowley M. F., Gabrien K. JT, Bloom A. Effect of short and long-term chlorpropamide treatment on insulin release and blood glucose. Lancet 1974; i: 69–72
   Google Scholar
• Feldman J. M., Lebovitz H. E. Appraisal of the extra-pancreatic actions of sulfonylureas. Arch Intern Med 1969; 123: 314–22
   PubMedGoogle Scholar
• Groop L., Groop P-H, Stenman S., Saloranta C., Tötterman K-J, Fyhrqvist F., Melander A. Do sulfonylureas influence hepatic insulin clearance?. Diabetes Care 1988; 11: 689–90
   PubMed Web of Science ®Google Scholar
• Nestler J. E., Clore J. N., Blackard W. G. Reduced insulin clearance in normal subjects due to external hyperinsulinemia. Am J Med Sci 1988; 295: 15–22
   PubMed Web of Science ®Google Scholar
• Levy J. R., Olefsky J. M. Retroendocytosis of insulin in rat adipocytes. Endocrinology 1986; 119: 527–79
   PubMed Web of Science ®Google Scholar
• Arner P., Einarsson K., Ewerth S., Livingston J. Studies of the human liver insulin receptor in non-insulin-dependent diabetes mellitus. J Clin Invest 1986; 77: 1716–8
   PubMed Web of Science ®Google Scholar
• Caro J. F., Ittoop O., Pories W. J., Meelheim D., Flickinger E. G., Thomas F., Jenquin M., Silverman J. F., Khazanie P. G., Sinha M. K. Studies on the mechanism of insulin resistance in the liver from humans with non-insulin-dependent diabetes. J Clin Invest 1986; 78: 249–58
   PubMed Web of Science ®Google Scholar
• Feinglos M. N., Lebovitz H. E. Sulphonylureas increase the number of insulin receptors. Nature 1978; 276: 184–5
   PubMed Web of Science ®Google Scholar
• Fleig W. E., Noether-Fleig G., Fussgaenger R., Dischuneit H. Modulation by a sulfonylurea of insulin-dependent glycogenesis, but not of insulin binding, in cultured rat hepatocytes. Evidence for a postreceptor mechanism of action. Diabetes 1984; 33: 285–90
   PubMed Web of Science ®Google Scholar
• Vigneri R., Pezzino V., Wong K. Y., Goldfine I. D. Comparison of the in vitro efect of biguanides and sulfonylureas on insulin binding to its receptors in target cells. J Cell Endocrin Metab 1982; 54: 95–100
   PubMed Web of Science ®Google Scholar
• Ishida T., Chou M. CY, Lewis R. M., Hartley C. J., Entman M., Field J. B. The effect of tolbutamide on hepatic extraction of insulin and glucagon and hepatic glucose output in anaesthetized dogs. Endocrinology 1981; 109: 443–50
   PubMed Web of Science ®Google Scholar
• Erwald R., Hed R., Nygren A., Rodjmark S., Sundblad L., Wiechel K-L. Immunoreactive insulin in the portal and the peripheral venous blood after intravenous tolbutamide administration. Diabetes 1971; 20: 686–90
   PubMed Web of Science ®Google Scholar
• Nygren A., Bulow G., Sundblad L., Thunberg E., Wiechel K-L. The effect of glipizide on extraction of insulin by the human cirrhotic and noncirrhotic liver. Metabolism 1988; 37: 810–14
   PubMed Web of Science ®Google Scholar
• Hosker J. P., Burnett M. A., Davies E. G., Harris E. A., Turner R. C. Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients. Diabetologia 1985; 28: 809–14
   PubMed Web of Science ®Google Scholar